biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Chiesi

<< Previous

Bullboard Posts

Next >>

Comment by craighenryon Jan 10, 2023 8:38am

116 Views

Post# 35212944

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Chiesi

Boomskid wrote: Yes, yes, poof, and the market just doesn't understand Midatech/Biodexa as well as you do.

No, no. I'm good. I get it.

Please convince beenthere. He thinks 50¢ is way over the top. He thinks less of you than I do, so as soon as you convince him, you can start on me.

jd

LoL. Ok Kettle!

Says the resident quack telling everyone only he is able to "read between the lines" for the past 10 years!!!

Just hilarious

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing